HomeCarbidopaCarbidopa + Tolcapone

Does Carbidopa Interact with Tolcapone?

Carbidopa and Tolcapone have a minor drug interaction according to U.S. FDA drug labeling data. No effects on pharmacokinetics of carbidopa observed despite tolcapone's potential to influence COMT substrate metabolism. The mechanism involves comt metabolism. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Minor
Carbidopa Class
Aromatic Amino Acid Decarboxylation Inhibitor
Tolcapone Class
Catechol-O-Methyltransferase Inhibitor
Management
Generally manageable
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Carbidopa and Tolcapone occurs because comt metabolism. Clinically, this means no effects on pharmacokinetics of carbidopa observed despite tolcapone's potential to influence comt substrate metabolism. This is classified as a minor interaction with generally low clinical significance, though your healthcare provider should still be informed that you are taking both medications.

What To Tell Your Doctor or Pharmacist

If you are taking Carbidopa and your doctor is considering prescribing Tolcapone (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Never stop or change either medication without first consulting your healthcare provider
💊 Carbidopa(Lodosyn)+💊 Tolcapone(Tolcapone)

Severity & Interaction Details

minor
Generally safe — minor interaction
Low clinical significance. Routine awareness is usually sufficient.
Severity scale
MinorContra
On record
Yes
Drug A class
Aromatic Amino Acid Decarboxylation Inhibitor
Drug B class
Catechol-O-Methyltransferase Inhibitor
Source
NLP:tolcapone

What this means in plain English

No effects on pharmacokinetics of carbidopa observed despite tolcapone's potential to influence COMT substrate metabolism.

What the FDA label says

"COMT metabolism"

📖 Source: NLP:tolcapone

Share this result:XFacebookWhatsAppReddit
Add more drugs
Check Carbidopa and Tolcapone against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.